S8 Ep36: FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer

Dr Gilbert discusses the FDA approval of dostarlimab in patients with endometrial cancer, key efficacy data from the GARNET trial, and how this agent bolsters the endometrial cancer treatment paradigm.